Immediate Impact

16 standout
Sub-graph 1 of 7

Citing Papers

Immunotherapy for glioblastoma: current state, challenges, and future perspectives
2024 Standout
Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design
2024 Standout
2 intermediate papers

Works of Carmen Baccarini being referenced

Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial
2022
Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of Age
2013

Author Peers

Author Last Decade Papers Cites
Carmen Baccarini 143 131 36 17 185
Ashleigh McGirr 213 138 52 14 250
John Ginis 267 150 26 9 295
John D. Farquhar 230 78 55 17 281
Jerzy Brzostek 185 77 61 14 232
Abián Montesdeoca Melián 97 41 36 17 136
Martina Kovac 137 20 29 14 175
E. A. M. Sanders 188 64 24 13 260
Soumeya Ouangraoua 141 110 14 23 172
May ElSherif 147 80 35 15 185
Javier Ruiz‐Guiñazú 146 92 26 21 182

All Works

Loading papers...

Rankless by CCL
2026